Iris Pharma

Iris Pharma is a specialized, full-service ophthalmic CRO with over three decades of experience. It offers a comprehensive suite of services including in vivo pharmacology, GLP-compliant safety and pharmacokinetics studies, bioanalysis, and clinical trial management. The company has contributed to the successful market approval of more than 70 products, positioning itself as a key partner for biopharma and medical device companies navigating the complex ocular therapeutics landscape.

Integrated suite of specialized ophthalmic research services including validated in vivo ocular disease models, GLP-compliant safety/pharmacokinetics studies, ocular bioanalytical testing, and strategic development consulting.

Iris Pharma competes in the niche ophthalmic CRO segment against other specialized firms and the ophthalmology divisions of large, global CROs (e.g., Syneos Health, Parexel, ICON). Its competitive advantage is its deep, exclusive focus on ophthalmology, long track record (>70 products to market), and integrated preclinical-to-clinical service offering.